Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
226-237
Author(s):
Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos
Meet Our Editorial Board Member:
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
199-199
Author(s):
Ingunn Holen
The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
275-286
Author(s):
Jui-Ling Tsai, Yu-May Lee, Chien-Yuan Pan and Alan Yueh-Luen Lee
Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs
Journal:
Current Pharmaceutical Biotechnology
Volume:
17
Page:
248-255
Author(s):
Dominique Duchene, Roberta Cavalli and Ruxandra Gref
Natural Endoperoxides as Drug Lead Compounds
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
383-405
Author(s):
Ming Bu, Burton B. Yang and Liming Hu
New Generation of Oncolytic Herpes Virus
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
163-177
Author(s):
Hiroshi Fukuhara and Tomoki Todo
Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
178-187
Author(s):
Toshiyoshi Fujiwara, Shunsuke Kagawa and Hiroshi Tazawa
Multi-modal Anti-cancer Activities Provided by a Non-replicating Sendai Virus Envelope
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
188-198
Author(s):
Yasufumi Kaneda
Meet Our Editorial Board Member:
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
133-134
Author(s):
Ramaswamy Narayanan
Armed Oncolytic Adenoviruses and Polymer-shielded Nanocomplex for Systemic Delivery
Journal:
Current Cancer Therapy Reviews
Volume:
11
Page:
136-153
Author(s):
A-Rum Yoon, Sung W. Kim and Chae-Ok Yun